CA
19
6
MDT
59
4
PWR
63
3
BMY
40
-5
EQIX
59
2
CTSH
55
3
ECL
54
5
ADI
54
4
EW
55
5
CAT
47
3
ESS
44
5
EXR
42
5
BK
60
2
PEG
53
7
AAPL
64
3
SYK
50
4
ETN
64
4
MAT
41
2
ACN
54
2
EQT
47
13
CA
19
6
MDT
59
4
PWR
63
3
BMY
40
-5
EQIX
59
2
CTSH
55
3
ECL
54
5
ADI
54
4
EW
55
5
CAT
47
3
ESS
44
5
EXR
42
5
BK
60
2
PEG
53
7
AAPL
64
3
SYK
50
4
ETN
64
4
MAT
41
2
ACN
54
2
EQT
47
13
Financhill
Back

AtriCure Vs. Perspective Therapeutics Industry Stock Comparison

Sell
33

ATRC
AtriCure

Last Price:
$30.74
Seasonality Move:
-0.28%
Sell
23

CATX
Perspective Therapeutics

Last Price:
$2.87
Seasonality Move:
41.25%
Sell
33
AtriCure (ATRC) is a Sell

Is AtriCure a Buy, Sell or Hold?

  • The current AtriCure [ATRC] share price is $30.73. The Score for ATRC is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • ATRC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $2.85. The Score for CATX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ATRC Stock Price Chart

What is AtriCure's stock price today?

  • The AtriCure share price today is $30.73
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATRC is experiencing buying pressure, which is a positive indicator for future bullish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $2.85
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight selling pressure.

ATRC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.95 Sell
Relative Strength Index (14 RSI): 34.32 Sell
Chaikin Money Flow: 401728 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.1 - 36.32) Sell
Bollinger Bands (100): (24.57 - 34.13) Buy

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.39 Sell
Relative Strength Index (14 RSI): 19.38 Sell
Chaikin Money Flow: -1073375 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.81 - 5.45) Sell
Bollinger Bands (100): (6.72 - 15.04) Sell

ATRC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 31.48 Sell
20-day SMA: 33.87 Sell
50-day SMA: 33.09 Sell
200-day SMA: 26.96 Buy
8-day EMA: 31.5 Sell
20-day EMA: 32.93 Sell
50-day EMA: 32.51 Sell
200-day EMA: 30.15 Buy

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.2 Sell
20-day SMA: 3.62 Sell
50-day SMA: 7.99 Sell
200-day SMA: 12.2 Sell
8-day EMA: 3.18 Sell
20-day EMA: 4.2 Sell
50-day EMA: 6.97 Sell
200-day EMA: 10.01 Sell

AtriCure Earnings Growth & ATRC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and an increase next year of $0.11 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.

AtriCure Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):